Committed to the fight against cancer and CNS disorders

Committed to the fight against cancer and CNS disorders

Astex Pharmaceuticals, Taiho Oncology, and Otsuka Pharmaceutical announce FDA and Health Canada approval of INQOVI^® (decitabine and cedazuridine) tablets.

Astex has built a rich product portfolio with multiple drugs in clinical development

Latest from Astex

7 July 2020

Astex Pharmaceuticals, Taiho Oncology, and Otsuka Pharmaceutical announce FDA and Health Canada approval of INQOVI® (decitabine and cedazuridine) tablets.

In The News

14 May 2020
Astex CSO, David Rees, elected as new Fellow of the Academy of Medical Sciences

Sustaining innovation

Innovative postdoctoral research fellowships

Career Opportunities

We seek to attract and retain talented individuals who are passionate about improving patient outcomes.